15/11/2024  08:16:23 Chg. -7.45 Volume Bid20:59:42 Ask20:59:42 Market Capitalization Dividend Y. P/E Ratio
226.85EUR -3.18% 0
Turnover: 0.00
226.90Bid Size: 140 227.65Ask Size: 140 44.97 bill.EUR - -

Business description

Cencora, formerly known as AmerisourceBergen, is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, Cencora delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.
 

Management board & Supervisory board

CEO
Steven H. Collis
Management board
James F. Cleary, Jr., Elizabeth S. Campbell, Gina K. Clark, Kourosh Q. Pirouz, Lazarus Krikorian, Leslie E. Donato, Robert P. Mauch, Silvana Battaglia, Jennifer Dubas
Supervisory board
Steven H. Collis, D. Mark Durcan, Dennis M. Nally, Henry W. McGee, Kathleen W. Hyle, Lon R. Greenberg, Ornella Barra, Richard W. Gochnauer, Redonda Miller, Lorence H. Kim, M.D.
 

Company data

Name: Cencora Inc
Address: 1 West First Avenue,Conshohocken, PA 19428-1800, USA
Phone: +1-610-727-7000
Fax: +1-800-640-5221
E-mail: InvestorRelations@cencora.com
Internet: https://www.cencora.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 30/09
Free Float: 55.10%
IPO date: 04/04/1995

Investor relations

Name: Bennett Murphy
IR phone: +1-610-727-3693
IR Fax: -
IR e-mail: bennett.murphy@cencora.com

Company calendar

CW 48 | 29/11/2024 Dividend Payment
 

Main Shareholders

Others
 
58.24%
Vanguard Group
 
10.28%
BlackRock Inc.
 
9.86%
PRICE T ROWE ASSOCIATES INC MD
 
5.36%
State Street Corporation
 
3.95%
JP Morgan Chase & Co.
 
2.73%
FMR LLC.
 
2.31%
Boston Partners
 
2.02%
Wellington Management Group
 
1.90%
Others
 
3.35%